Companies Teladoc Health, Inc.
Teladoc Health (TDOC): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Teladoc Health, Inc.’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers39th pct.Of 19 peer CEOs
CEO pay, last three years
- $16,061,267FY2024
- $11,202,996FY2025
CEO total pay was $11,202,996 in fiscal 2025, down from $16,061,267 in fiscal 2024.
FY2025: salary $800,000 · bonus $0 · stock awards $9,699,996 · option awards $0
Executives and directors
Adam Vandervoort · General CounselCarlos Nueno · PresidentCharles Divita, III · CEOKelly Bliss · PresidentMala Murthy · Chief Financial OfficerCatherine A. Jacobson · Independent DirectorDavid B. Snow, Jr · Independent DirectorDavid L. Shedlarz · Independent DirectorJ. Eric Evans · Independent DirectorKenneth H. Paulus · Chair of the BoardMark Douglas Smith, M.D., MBA · Independent DirectorMichael S. Smith · Independent DirectorSandra L. Fenwick · Independent DirectorSusan R. Salka · Independent DirectorThomas G. McKinley · Independent Director
Frequently asked questions
Who was the highest-paid executive at Teladoc Health, Inc. in fiscal 2025?
As disclosed, Charles Divita, III (Chief Executive Officer) was the highest-paid executive at Teladoc Health, Inc. in fiscal 2025, with total compensation of $11,202,996.
How does Teladoc Health, Inc.'s chief executive pay compare to its disclosed peer group?
As disclosed, Charles Divita, III's total compensation ranked at the 39th percentile of Teladoc Health, Inc.'s disclosed peer group.
What is Teladoc Health, Inc.'s CEO-to-median employee pay ratio?
As disclosed, Teladoc Health, Inc.'s CEO-to-median employee pay ratio was 127.6:1.
How did shareholders vote on Teladoc Health, Inc.'s executive compensation?
As disclosed, 88.8% of shareholders supported Teladoc Health, Inc.'s executive compensation in the latest say-on-pay vote.
How much does Teladoc Health, Inc. spend in total on board compensation for fiscal 2025?
As disclosed, Teladoc Health, Inc. reported total board compensation of $2,152,524 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Charles Divita, III | $800,000 | $0 | $9,699,996 | $0 | $584,000 | $0 | $119,000 | $11,202,996 |
| Chief Executive Officer | ||||||||
| Mala Murthy | 489,375 | 0 | 3,299,998 | 0 | 0 | 0 | 14,000 | 3,803,373 |
| Former Chief Financial Officer | ||||||||
| Carlos Nueno | 589,552 | 0 | 2,000,000 | 0 | 564,201 | 0 | 95,373 | 3,249,126 |
| President, International | ||||||||
| Kelly Bliss | 516,667 | 0 | 2,099,997 | 0 | 331,500 | 0 | 14,000 | 2,962,164 |
| President, U.S. Group Health | ||||||||
| Adam Vandervoort | 495,000 | 0 | 2,099,997 | 0 | 247,000 | 0 | 14,000 | 2,855,997 |
| Chief Legal Officer and Secretary | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Charles Divita, III | $11,202,996 | $16,061,267 | — | ↓ −4,858,271 |
| Mala Murthy | 3,803,373 | 5,230,694 | 5,944,842 | ↓ −1,427,321 |
| Carlos Nueno | 3,249,126 | 2,739,138 | — | ↑ +509,988 |
| Kelly Bliss | 2,962,164 | 2,514,739 | — | ↑ +447,425 |
| Adam Vandervoort | 2,855,997 | 2,634,319 | 3,535,845 | ↑ +221,678 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Paying for performance is a key attribute of our compensation philosophy. Fundamentally, our executive compensation program links compensation to the achievement of specific, predetermined financial and performance goals that further our business strategies.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Mala Murthy | RSU | 2025-03-01 | — | — | 172,594 | — | $1,649,999 |
| Adam Vandervoort | PSU | 2025-03-01 | — | 109,833 | — | 219,666 | 1,050,003 |
| Mala Murthy | PSU | 2025-03-01 | — | 172,594 | — | 345,188 | 1,649,999 |
| Carlos Nueno | PSU | 2025-03-01 | — | 104,603 | — | 209,206 | 1,000,005 |
| Kelly Bliss | RSU | 2025-03-01 | — | — | 109,832 | — | 1,049,994 |
| Kelly Bliss | PSU | 2025-03-01 | — | 109,833 | — | 219,666 | 1,050,003 |
| Charles Divita, III | PSU | 2025-03-01 | — | 507,322 | — | 1,014,644 | 4,849,998 |
| Adam Vandervoort | RSU | 2025-03-01 | — | — | 109,832 | — | 1,049,994 |
| Charles Divita, III | RSU | 2025-03-01 | — | — | 507,322 | — | 4,849,998 |
| Carlos Nueno | RSU | 2025-03-01 | — | — | 104,602 | — | 999,995 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Mala Murthy | $1,649,999 | $1,649,999 | $0 | 50.0% |
| Adam Vandervoort | 1,049,994 | 1,050,003 | 0 | 50.0% |
| Carlos Nueno | 999,995 | 1,000,005 | 0 | 50.0% |
| Kelly Bliss | 1,049,994 | 1,050,003 | 0 | 50.0% |
| Charles Divita, III | 4,849,998 | 4,849,998 | 0 | 50.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Carlos Nueno | RSU | 1,061 | — | $7,427 |
| Kelly Bliss | RSU | 1,186 | — | 8,302 |
| Adam Vandervoort | RSU | 1,510 | — | 10,570 |
| Carlos Nueno | RSU | 3,101 | — | 21,707 |
| Kelly Bliss | RSU | 3,488 | — | 24,416 |
| Adam Vandervoort | RSU | 4,418 | — | 30,926 |
| Carlos Nueno | RSU | 7,440 | — | 52,080 |
| Kelly Bliss | RSU | 8,371 | — | 58,597 |
| Adam Vandervoort | RSU | 10,603 | — | 74,221 |
| Carlos Nueno | RSU | 22,782 | — | 159,474 |
| Kelly Bliss | RSU | 24,293 | — | 170,051 |
| Adam Vandervoort | RSU | 26,750 | — | 187,250 |
| Carlos Nueno | RSU | 27,337 | — | 191,359 |
| Kelly Bliss | RSU | 27,458 | — | 192,206 |
| Adam Vandervoort | RSU | 27,458 | — | 192,206 |
| Kelly Bliss | RSU | 29,150 | — | 204,050 |
| Adam Vandervoort | RSU | 32,100 | — | 224,700 |
| Kelly Bliss | RSU | 82,375 | — | 576,625 |
| Adam Vandervoort | RSU | 82,375 | — | 576,625 |
| Carlos Nueno | RSU | 104,602 | — | 732,214 |
| Carlos Nueno | RSU | 104,603 | — | 732,221 |
| Kelly Bliss | RSU | 109,832 | — | 768,824 |
| Adam Vandervoort | RSU | 109,832 | — | 768,824 |
| Charles Divita, III | RSU | 126,831 | — | 887,817 |
| Charles Divita, III | RSU | 234,962 | — | 1,644,734 |
| Charles Divita, III | RSU | 234,963 | — | 1,644,741 |
| Charles Divita, III | RSU | 380,491 | — | 2,663,437 |
| Charles Divita, III | RSU | 507,322 | — | 3,551,254 |
| Charles Divita, III | RSU | 704,887 | — | 4,934,209 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| David B. Snow, JrIndependent · Audit · Compensation | $84,011 | $200,003 | $0 | $0 | $0 | $284,014 |
| Kenneth H. PaulusIndependent · Board Chair · Nominating and Corporate Governance · Compensation · Executive | 83,489 | 200,003 | 0 | 0 | 0 | 283,492 |
| J. Eric EvansIndependent · Audit · Compensation (Chair) · Executive · Not standing for re-election | 75,000 | 200,003 | 0 | 0 | 0 | 275,003 |
| David L. ShedlarzIndependent · Audit (Chair) · Compensation | 72,500 | 200,003 | 0 | 0 | 0 | 272,503 |
| Thomas G. McKinleyIndependent · Audit · Compensation · Not standing for re-election | 62,500 | 200,003 | 0 | 0 | 0 | 262,503 |
| Mark Douglas Smith, M.D., MBAIndependent · Quality of Care and Patient Safety | 60,000 | 200,003 | 0 | 0 | 0 | 260,003 |
| Catherine A. JacobsonIndependent · Nominating and Corporate Governance (Chair) · Quality of Care and Patient Safety · Executive | 60,000 | 200,003 | 0 | 0 | 0 | 260,003 |
| Sandra L. FenwickIndependent · Compensation (Chair) · Quality of Care and Patient Safety · Executive | 55,000 | 200,003 | 0 | 0 | 0 | 255,003 |
| Susan R. SalkaIndependent · Audit · Partial-year service · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Michael S. SmithIndependent · Audit · Partial-year service · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Charles Divita, IIIEmployee director · Executive | 0 | 0 | 0 | — | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $45,000 |
|---|---|
| Annual equity retainer | $200,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 20,000 / 10,000 |
| Stock ownership guideline | $135,000 |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $552,500 |
| Equity awards (grant-date value) | $1,600,024 |
| All other compensation | $0 |
| Total cost of the board | $2,152,524 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Teladoc Health as a peer
Companies that benchmark against TDOC
15 companies name TDOC as a compensation peer
The list of companies that name TDOC as a peer is temporarily unavailable — recheck shortly.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
EVH Evolent Health, Inc.AMN AMN Healthcare Services, Inc.CLOV Clover Health Investments, Corp.DOCU DocuSign, Inc.EEFT Euronet Worldwide, Inc.MEDP Medpace, Inc.NTNX Nutanix, Inc.MD Pediatrix Medical Group, Inc.PINC Premier Inc.RNG RingCentral, Inc.TWLO Twilio Inc.AGL Agilon Health, Inc.ALHC Alignment Healthcare, Inc.ASTH Astrana Health, Inc.AVAH Aveanna Healthcare Holdings Inc.DBX Dropbox, Inc.MMS Maximus Inc. OpenText CorporationPRVA Privia Health Group, Inc.
Peer reciprocity
Of the companies Teladoc Health, Inc. names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
✓ Evolent Health, Inc. (EVH)160✓ AMN Healthcare Services, Inc. (AMN)161— Clover Health Investments, Corp. (CLOV)162— DocuSign, Inc. (DOCU)163 Euronet Worldwide, Inc. (EEFT)— Medpace, Inc. (MEDP)164— Nutanix, Inc. (NTNX)165 Pediatrix Medical Group, Inc. (MD)— Premier Inc. (PINC)166— RingCentral, Inc. (RNG)167— Twilio Inc. (TWLO)168✓ Agilon Health, Inc. (AGL)169✓ Alignment Healthcare, Inc. (ALHC)170 Astrana Health, Inc. (ASTH)— Aveanna Healthcare Holdings Inc. (AVAH)171— Dropbox, Inc. (DBX)172— Maximus Inc. (MMS)173✓ Privia Health Group, Inc. (PRVA)174
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Teladoc Health, Inc..
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Nutanix, Inc. | 2026 | Rajiv Ramaswami | $800,000 | $27,883,613 | $0 | $797,600 | $29,485,213 |
| 2 | DocuSign, Inc. | 2026 | Allan Thygesen | 1,000,000 | 23,600,136 | 0 | 1,019,000 | 25,650,100 |
| 3 | Twilio Inc. | 2025 | Khozema Shipchandler | 1,100,000 | 21,398,539 | 0 | 1,507,000 | 24,291,917 |
| 4 | RingCentral, Inc. | 2024 | Vladimir Shmunis | 376,367 | 14,565,146 | 0 | 533,311 | 15,491,096 |
| 5 | Astrana Health, Inc. | 2025 | Brandon Sim | 850,000 | 11,999,980 | 0 | 2,059,125 | 14,930,231 |
| 6 | Evolent Health, Inc. | 2025 | Seth Blackley | 867,068 | 12,699,086 | 0 | 0 | 14,240,154 |
| 7 | Pediatrix Medical Group, Inc. | 2025 | Mark Ordan | 970,014 | 8,456,024 | 0 | 2,700,000 | 14,140,217 |
| 8 | Premier Inc. | 2024 | Michael Alkire | 1,095,876 | 8,500,039 | 0 | 1,800,150 | 11,806,381 |
| 9 | Medpace, Inc. | 2025 | August Troendle | 937,417 | 0 | 9,999,999 | 0 | 11,443,766 |
| 10 | Alignment Healthcare, Inc. | 2025 | John Kao | 833,654 | 8,500,014 | 0 | 1,944,495 | 11,278,583 |
| 11 | Maximus Inc. | 2025 | Bruce Caswell | 976,923 | 6,862,177 | 0 | 3,300,000 | 11,210,668 |
| 12 | Teladoc Health, Inc. | 2025 | Charles Divita, III | 800,000 | 9,699,996 | 0 | 584,000 | 11,202,996 |
| 13 | AMN Healthcare Services, Inc. | 2025 | Cary Grace | 1,060,000 | 8,363,117 | 0 | 1,146,125 | 10,669,780 |
| 14 | Privia Health Group, Inc. | 2025 | Parth Mehrotra | 650,000 | 8,588,373 | 0 | 1,218,750 | 10,472,698 |
| 15 | Agilon Health, Inc. | 2025 | Jeffrey Schwaneke | 625,000 | 2,950,003 | 1,750,000 | 271,875 | 5,610,878 |
| 16 | Aveanna Healthcare Holdings Inc. | 2025 | Jeffrey Shaner | 750,000 | 2,603,993 | 0 | 1,500,000 | 4,864,165 |
| 17 | Euronet Worldwide, Inc. | 2025 | Michael Brown | 925,000 | 0 | 0 | 1,850,000 | 2,786,575 |
| 18 | Dropbox, Inc. | 2025 | Andrew Houston | 800,000 | 0 | 0 | 750,400 | 2,166,622 |
| 19 | Clover Health Investments, Corp. | 2025 | Andrew Toy | 800,000 | 0 | 0 | 509,539 | 1,319,385 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Teladoc Health, Inc. | 73% | RSU 50 · PSU 50 | No | Aon |
| Agilon Health, Inc. | 58% | not disclosed | No | Semler Brossy |
| Alignment Healthcare, Inc. | 200% | not disclosed | No | FW Cook |
| AMN Healthcare Services, Inc. | 87% | not disclosed | Yes — Relative TSR | FW Cook |
| Astrana Health, Inc. | 193.8% | PSU 67 · RSU 33 | No | Pearl Meyer |
| Aveanna Healthcare Holdings Inc. | 200% | PSU 50 · RSU 50 | No | Aon Human Capital Solutions (division of Aon plc) |
| Clover Health Investments, Corp. | 64% | RSU 60 · Cash LTI 40 | No | Aon, plc (Human Capital Practice) |
| DocuSign, Inc. | 101.9% | PSU 60 · RSU 40 | Yes — TSR | Compensia |
| Dropbox, Inc. | 107.3% | RSU 100 | not disclosed | Compensia |
| Euronet Worldwide, Inc. | 200% | PRSU 100 | No | FW Cook |
| Evolent Health, Inc. | 75% | PSU 70 · RSU 30 | No | Exequity |
| Maximus Inc. | 220.0% | PSU 50 · RSU 50 | No | FW Cook |
| Medpace, Inc. | 52.5% | Options 100 | not disclosed | Total Compensation Solutions (TCS) |
| Nutanix, Inc. | 99.7% | RSU 50 · PSU 50 | Yes — Relative TSR vs Nasdaq Composite Index | Compensia |
| Pediatrix Medical Group, Inc. | 180% | RSU 50 · PSU 50 | No | Semler Brossy Consulting Group |
| Premier Inc. | 109.1% | PSU 60 · RSU 40 | No | Mercer |
| Privia Health Group, Inc. | 150% | PSU 60 · RSU 40 | No | Korn Ferry (through September 2025), WTW (starting September 2025) |
| RingCentral, Inc. | not disclosed | not disclosed | No | Compensia |
| Twilio Inc. | 137.0% | PSU 60 · RSU 40 | Yes | Compensia |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-21 | 71,154,268 | 8,973,257 | 1,158,116 | 88.8% | Passed |
| 2025 | 2025-05-22 | 61,160,355 | 22,179,678 | 181,702 | 73.39% | Passed |
| 2024 | 2024-05-23 | 86,004,216 | 3,679,987 | 247,426 | 95.9% | Passed |
| 2023 | 2023-05-25 | 74,437,080 | 16,406,746 | 486,180 | 81.94% | Passed |
| 2022 | 2022-05-26 | 80,030,674 | 7,339,906 | 219,882 | 91.6% | Passed |
| 2021 | 2021-05-17 | 72,534,520 | 10,671,743 | 354,119 | 87.17% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-05-21 | 88.8%a |
| 2025 | 2025-05-22 | 73.39%b |
| 2024 | 2024-05-23 | 95.9%c |
a. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on any of the proposals included in this proxy statement.”.
b. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on any of the proposals included in this proxy statement.”.
c. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on any of the proposals included in this proxy statement.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 127.6 : 1 |
|---|---|
| CEO total compensation | $11,202,996 |
| Median employee compensation | $87,811 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| David B. Snow, Jr | Director | 2026-05-20 | D | 28,986 | $0 | $0 | Derivative, Class A Common | Form 4 ↗ |
| David B. Snow, Jr | Director | 2026-05-20 | A | 28,986 | — | — | Common | Form 4 ↗ |
| Catherine A. Jacobson | Director | 2026-05-20 | D | 28,986 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Catherine A. Jacobson | Director | 2026-05-20 | A | 28,986 | — | — | Common | Form 4 ↗ |
| David L. Shedlarz | Director | 2026-05-20 | D | 28,986 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David L. Shedlarz | Director | 2026-05-20 | A | 29,986 | — | — | Common | Form 4 ↗ |
| David L. Shedlarz | Director | 2026-05-21 | A | 30,441 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Sandra L. Fenwick | Director | 2026-05-21 | A | 30,441 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David B. Snow, Jr | Director | 2026-05-21 | A | 30,441 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth H. Paulus | Director | 2026-05-21 | A | 30,441 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael S. Smith | Director | 2026-05-21 | A | 30,441 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Catherine A. Jacobson | Director | 2026-05-21 | A | 30,441 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-01 | A | 1,042 | — | — | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-01 | A | 9,152 | — | — | Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-06-01 | A | 5,350 | — | — | Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-06-01 | A | 426 | — | — | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-06-01 | — | 5,606 | — | — | 5 insiders, 6 accrual rows | ||
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-01 | D | 5,491 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-06-01 | D | 9,152 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-06-01 | D | 5,350 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-06-01 | A | 9,152 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-01 | D | 42,276 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-01 | A | 42,276 | — | — | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-01 | D | 9,152 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-01 | D | 4,858 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-01 | A | 4,858 | — | — | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-01 | A | 1,300 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-06-01 | A | 833 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-06-01 | A | 39 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-01 | A | 1,966 | — | — | Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-06-01 | D | 8,716 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-06-01 | D | 4,556 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-06-01 | A | 8,716 | — | — | Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-06-01 | A | 4,556 | — | — | Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-01 | D | 8,716 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-01 | A | 8,716 | — | — | Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-01 | A | 5,491 | — | — | Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-02 | D | 5,677 | 8 | 43,298 | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-02 | D | 19,132 | 8 | 145,920 | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-02 | D | 7,679 | 8 | 58,568 | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-06-02 | D | 284 | 8 | 2,166 | Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-06-02 | D | 6,196 | 8 | 47,257 | Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-06-02 | D | 7,906 | 8 | 60,299 | Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-03 | D | 9,572 | 7 | 70,833 | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-10 | D | 39,160 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-10 | D | 3,642 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-10 | A | 39,160 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-10 | A | 3,642 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-11 | D | 18,074 | 7 | 125,470 | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-29 | D | 2,500 | 9 | 21,250 | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-07-01 | D | 2,500 | 9 | 22,500 | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-07-01 | D | 2,083 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-07-01 | A | 2,083 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-07-02 | D | 653 | 9 | 5,942 | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-07-06 | D | 2,500 | 10 | 23,750 | Common | Form 4 ↗ |
| Mark Anquillare V | Director | 2026-08-03 | A | 37,425 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-09-01 | A | 5,350 | — | — | Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-09-01 | A | 4,556 | — | — | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-09-01 | D | 9,152 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-09-01 | D | 4,556 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-01 | A | 8,717 | — | — | Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-01 | A | 1,042 | — | — | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-09-01 | — | 5,606 | — | — | 5 insiders, 6 accrual rows | ||
| Charles Divita, III | Director | 2026-09-01 | A | 1,966 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-01 | A | 42,277 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-09-01 | A | 39 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-09-01 | A | 833 | — | — | Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-09-01 | D | 9,152 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-09-01 | D | 5,350 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-09-01 | A | 426 | — | — | Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-09-01 | A | 9,152 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-01 | D | 42,277 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael F. Grasher | Chief Financial Officer | 2026-09-01 | A | 239,616 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-01 | D | 8,717 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-01 | D | 5,492 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-01 | A | 5,492 | — | — | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-09-01 | D | 4,859 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-09-01 | A | 1,300 | — | — | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-09-01 | A | 9,152 | — | — | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-09-01 | A | 4,859 | — | — | Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-09-01 | D | 8,717 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-09-01 | A | 8,717 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-09-02 | D | 274 | 6 | 1,726 | Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-09-02 | D | 7,573 | 6 | 47,717 | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-02 | D | 18,327 | 6 | 115,478 | Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-02 | D | 5,439 | 6 | 34,271 | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-09-02 | D | 7,357 | 6 | 46,356 | Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-09-02 | D | 6,200 | 6 | 39,066 | Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-03 | D | 9,812 | 7 | 63,876 | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-10 | D | 39,160 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-10 | D | 3,642 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-10 | A | 39,160 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-10 | A | 3,642 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-11 | D | 17,805 | 6 | 108,682 | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-10-01 | D | 2,083 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-10-01 | A | 2,083 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-10-02 | D | 655 | 6 | 3,703 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
View all 107 transactions
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| David B. Snow, Jr | Director | 2026-05-20 | D | 28,986 | $0 | $0 | Derivative, Class A Common | Form 4 ↗ |
| David B. Snow, Jr | Director | 2026-05-20 | A | 28,986 | — | — | Common | Form 4 ↗ |
| Catherine A. Jacobson | Director | 2026-05-20 | D | 28,986 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Catherine A. Jacobson | Director | 2026-05-20 | A | 28,986 | — | — | Common | Form 4 ↗ |
| David L. Shedlarz | Director | 2026-05-20 | D | 28,986 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David L. Shedlarz | Director | 2026-05-20 | A | 29,986 | — | — | Common | Form 4 ↗ |
| David L. Shedlarz | Director | 2026-05-21 | A | 30,441 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Sandra L. Fenwick | Director | 2026-05-21 | A | 30,441 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David B. Snow, Jr | Director | 2026-05-21 | A | 30,441 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth H. Paulus | Director | 2026-05-21 | A | 30,441 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael S. Smith | Director | 2026-05-21 | A | 30,441 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Catherine A. Jacobson | Director | 2026-05-21 | A | 30,441 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-01 | A | 1,042 | — | — | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-01 | A | 9,152 | — | — | Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-06-01 | A | 5,350 | — | — | Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-06-01 | A | 426 | — | — | Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-06-01 | D | 426 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-06-01 | D | 833 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-01 | D | 1,042 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-01 | D | 5,491 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-06-01 | D | 9,152 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-06-01 | D | 5,350 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-06-01 | A | 9,152 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-01 | D | 42,276 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-01 | D | 1,966 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-01 | A | 42,276 | — | — | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-01 | D | 9,152 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-01 | D | 4,858 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-01 | D | 1,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-01 | A | 4,858 | — | — | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-01 | A | 1,300 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-06-01 | D | 39 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-06-01 | A | 833 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-06-01 | A | 39 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-01 | A | 1,966 | — | — | Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-06-01 | D | 8,716 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-06-01 | D | 4,556 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-06-01 | A | 8,716 | — | — | Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-06-01 | A | 4,556 | — | — | Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-01 | D | 8,716 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-01 | A | 8,716 | — | — | Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-01 | A | 5,491 | — | — | Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-02 | D | 5,677 | 8 | 43,298 | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-02 | D | 19,132 | 8 | 145,920 | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-02 | D | 7,679 | 8 | 58,568 | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-06-02 | D | 284 | 8 | 2,166 | Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-06-02 | D | 6,196 | 8 | 47,257 | Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-06-02 | D | 7,906 | 8 | 60,299 | Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-06-03 | D | 9,572 | 7 | 70,833 | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-10 | D | 39,160 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-10 | D | 3,642 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-10 | A | 39,160 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-10 | A | 3,642 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-06-11 | D | 18,074 | 7 | 125,470 | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-06-29 | D | 2,500 | 9 | 21,250 | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-07-01 | D | 2,500 | 9 | 22,500 | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-07-01 | D | 2,083 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-07-01 | A | 2,083 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-07-02 | D | 653 | 9 | 5,942 | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-07-06 | D | 2,500 | 10 | 23,750 | Common | Form 4 ↗ |
| Mark Anquillare V | Director | 2026-08-03 | A | 37,425 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-09-01 | A | 5,350 | — | — | Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-09-01 | A | 4,556 | — | — | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-09-01 | D | 9,152 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-09-01 | D | 4,556 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-01 | A | 8,717 | — | — | Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-01 | A | 1,042 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-01 | D | 1,966 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-01 | A | 1,966 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-01 | A | 42,277 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-09-01 | D | 39 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-09-01 | A | 39 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-09-01 | A | 833 | — | — | Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-09-01 | D | 9,152 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-09-01 | D | 426 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-09-01 | D | 5,350 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-09-01 | A | 426 | — | — | Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-09-01 | A | 9,152 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-01 | D | 42,277 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael F. Grasher | Chief Financial Officer | 2026-09-01 | A | 239,616 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-01 | D | 8,717 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-01 | D | 1,042 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-01 | D | 5,492 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-01 | A | 5,492 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-09-01 | D | 833 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-09-01 | D | 1,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-09-01 | D | 4,859 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-09-01 | A | 1,300 | — | — | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-09-01 | A | 9,152 | — | — | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-09-01 | A | 4,859 | — | — | Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-09-01 | D | 8,717 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-09-01 | A | 8,717 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-09-02 | D | 274 | 6 | 1,726 | Common | Form 4 ↗ |
| Adam Vandervoort | Chief Legal Officer, Secretary | 2026-09-02 | D | 7,573 | 6 | 47,717 | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-02 | D | 18,327 | 6 | 115,478 | Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-02 | D | 5,439 | 6 | 34,271 | Common | Form 4 ↗ |
| Kelly Bliss | President, U.S. Group Health | 2026-09-02 | D | 7,357 | 6 | 46,356 | Common | Form 4 ↗ |
| Carlos Nueno | President, International | 2026-09-02 | D | 6,200 | 6 | 39,066 | Common | Form 4 ↗ |
| Fernando M. Rodrigues | President of BetterHelp | 2026-09-03 | D | 9,812 | 7 | 63,876 | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-10 | D | 39,160 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-10 | D | 3,642 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-10 | A | 39,160 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-10 | A | 3,642 | — | — | Common | Form 4 ↗ |
| Charles Divita, III | Director | 2026-09-11 | D | 17,805 | 6 | 108,682 | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-10-01 | D | 2,083 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-10-01 | A | 2,083 | — | — | Common | Form 4 ↗ |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026-10-02 | D | 655 | 6 | 3,703 | Common | Form 4 ↗ |
Sources (174 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Charles Divita, III. DEF 14A, filed 2026-04-07. Section “2025 Summary Compensation Table” · page 47. As printed: 11,202,996. View filing ↗
- Section 01, Mala Murthy. DEF 14A, filed 2026-04-07. Section “2025 Summary compensation table” · page 47. As printed: 3,803,373. View filing ↗
- Section 01, Carlos Nueno. DEF 14A, filed 2026-04-07. Section “2025 Summary compensation table” · page 47. As printed: 3,249,126. View filing ↗
- Section 01, Kelly Bliss. DEF 14A, filed 2026-04-07. Section “2025 Summary compensation table” · page 47. As printed: 2,962,164. View filing ↗
- Section 01, Adam Vandervoort. DEF 14A, filed 2026-04-07. Section “2025 Summary compensation table” · page 47. As printed: 2,855,997. View filing ↗
- Section 03, Mala Murthy RSU. DEF 14A, filed 2026-04-07. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Adam Vandervoort PSU. DEF 14A, filed 2026-04-07. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Mala Murthy PSU. DEF 14A, filed 2026-04-07. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Carlos Nueno PSU. DEF 14A, filed 2026-04-07. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Kelly Bliss RSU. DEF 14A, filed 2026-04-07. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Kelly Bliss PSU. DEF 14A, filed 2026-04-07. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Charles Divita, III PSU. DEF 14A, filed 2026-04-07. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Adam Vandervoort RSU. DEF 14A, filed 2026-04-07. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Charles Divita, III RSU. DEF 14A, filed 2026-04-07. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Carlos Nueno RSU. DEF 14A, filed 2026-04-07. Section “2025 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-07. Section “CEO Pay Ratio”. As printed: 127.6 : 1. View filing ↗
- Section 08, David B. Snow, Jr. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 284,014. View filing ↗
- Section 08, Kenneth H. Paulus. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 283,492. View filing ↗
- Section 08, J. Eric Evans. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 275,003. View filing ↗
- Section 08, David L. Shedlarz. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 272,503. View filing ↗
- Section 08, Thomas G. McKinley. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 262,503. View filing ↗
- Section 08, Mark Douglas Smith, M.D., MBA. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 260,003. View filing ↗
- Section 08, Catherine A. Jacobson. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 260,003. View filing ↗
- Section 08, Sandra L. Fenwick. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 255,003. View filing ↗
- Section 08, Susan R. Salka. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Michael S. Smith. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Charles Divita, III. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, David B. Snow, Jr 2026-05-20. Form 4, filed 2026-05-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David B. Snow, Jr 2026-05-20. Form 4, filed 2026-05-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Catherine A. Jacobson 2026-05-20. Form 4, filed 2026-05-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Catherine A. Jacobson 2026-05-20. Form 4, filed 2026-05-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David L. Shedlarz 2026-05-20. Form 4, filed 2026-05-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David L. Shedlarz 2026-05-20. Form 4, filed 2026-05-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David L. Shedlarz 2026-05-21. Form 4, filed 2026-05-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Sandra L. Fenwick 2026-05-21. Form 4, filed 2026-05-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David B. Snow, Jr 2026-05-21. Form 4, filed 2026-05-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth H. Paulus 2026-05-21. Form 4, filed 2026-05-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael S. Smith 2026-05-21. Form 4, filed 2026-05-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Catherine A. Jacobson 2026-05-21. Form 4, filed 2026-05-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam Vandervoort 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam Vandervoort 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam Vandervoort 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam Vandervoort 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam Vandervoort 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam Vandervoort 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Carlos Nueno 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Carlos Nueno 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Carlos Nueno 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Carlos Nueno 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-06-02. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-06-02. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-06-02. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-06-02. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Carlos Nueno 2026-06-02. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam Vandervoort 2026-06-02. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-06-03. Form 4, filed 2026-06-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-06-10. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-06-10. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-06-10. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-06-10. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-06-11. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-06-29. Form 4, filed 2026-06-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-07-01. Form 4, filed 2026-07-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-07-02. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-07-06. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Anquillare V 2026-08-03. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam Vandervoort 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Carlos Nueno 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Carlos Nueno 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam Vandervoort 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam Vandervoort 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam Vandervoort 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam Vandervoort 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam Vandervoort 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael F. Grasher 2026-09-01. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Carlos Nueno 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Carlos Nueno 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-09-02. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam Vandervoort 2026-09-02. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-09-02. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-09-02. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kelly Bliss 2026-09-02. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Carlos Nueno 2026-09-02. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Fernando M. Rodrigues 2026-09-03. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-09-10. Form 4, filed 2026-09-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-09-10. Form 4, filed 2026-09-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-09-10. Form 4, filed 2026-09-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-09-10. Form 4, filed 2026-09-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Charles Divita, III 2026-09-11. Form 4, filed 2026-09-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-10-01. Form 4, filed 2026-10-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-10-01. Form 4, filed 2026-10-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph Ronald Catapano 2026-10-02. Form 4, filed 2026-10-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-05-21. Item 5.07 · say-on-pay result. As reported: 88.8% (votes for as printed: 71,154,268). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-05-23. Item 5.07 · say-on-pay result. As reported: 73.39% (votes for as printed: 61,160,355). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-05-24. Item 5.07 · say-on-pay result. As reported: 95.9% (votes for as printed: 86,004,216). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 552,500 + equity 1,600,024 + all other 0 = 2,152,524, summed across the director compensation table rows.
- Nutanix, Inc., Section 10b CEO total. DEF 14A, filed 2026-10-20. CEO total compensation as printed in Nutanix, Inc.'s own proxy. As printed: 29,485,213. View filing ↗
- DocuSign, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-16. CEO total compensation as printed in DocuSign, Inc.'s own proxy. As printed: 25,650,100. View filing ↗
- Twilio Inc., Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Twilio Inc.'s own proxy. As printed: 24,291,917. View filing ↗
- RingCentral, Inc., Section 10b CEO total. DEF 14A, filed 2025-12-09. CEO total compensation as printed in RingCentral, Inc.'s own proxy. As printed: 15,491,096. View filing ↗
- Astrana Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-17. CEO total compensation as printed in Astrana Health, Inc.'s own proxy. As printed: 14,930,231. View filing ↗
- Evolent Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Evolent Health, Inc.'s own proxy. As printed: 14,240,154. View filing ↗
- Pediatrix Medical Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Pediatrix Medical Group, Inc.'s own proxy. As printed: 14,140,217. View filing ↗
- Premier Inc., Section 10b CEO total. DEF 14A, filed 2024-10-21. CEO total compensation as printed in Premier Inc.'s own proxy. As printed: 11,806,381. View filing ↗
- Medpace, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-01. CEO total compensation as printed in Medpace, Inc.'s own proxy. As printed: 11,443,766. View filing ↗
- Alignment Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Alignment Healthcare, Inc.'s own proxy. As printed: 11,278,583. View filing ↗
- Maximus Inc., Section 10b CEO total. DEF 14A, filed 2026-01-22. CEO total compensation as printed in Maximus Inc.'s own proxy. As printed: 11,210,668. View filing ↗
- Teladoc Health, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Teladoc Health, Inc.'s own proxy. As printed: 11,202,996. View filing ↗
- AMN Healthcare Services, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-18. CEO total compensation as printed in AMN Healthcare Services, Inc.'s own proxy. As printed: 10,669,780. View filing ↗
- Privia Health Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Privia Health Group, Inc.'s own proxy. As printed: 10,472,698. View filing ↗
- Agilon Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in Agilon Health, Inc.'s own proxy. As printed: 5,610,878. View filing ↗
- Aveanna Healthcare Holdings Inc., Section 10b CEO total. DEF 14A, filed 2026-04-17. CEO total compensation as printed in Aveanna Healthcare Holdings Inc.'s own proxy. As printed: 4,864,165. View filing ↗
- Euronet Worldwide, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-13. CEO total compensation as printed in Euronet Worldwide, Inc.'s own proxy. As printed: 2,786,575. View filing ↗
- Dropbox, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Dropbox, Inc.'s own proxy. As printed: 2,166,622. View filing ↗
- Clover Health Investments, Corp., Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Clover Health Investments, Corp.'s own proxy. As printed: 1,319,385. View filing ↗
- Section 10a, Evolent Health, Inc. reciprocity. DEF 14A. Evolent Health, Inc. names Teladoc Health, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, AMN Healthcare Services, Inc. reciprocity. DEF 14A. AMN Healthcare Services, Inc. names Teladoc Health, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Clover Health Investments, Corp. reciprocity. DEF 14A. Clover Health Investments, Corp.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health, Inc.. View filing ↗
- Section 10a, DocuSign, Inc. reciprocity. DEF 14A. DocuSign, Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health, Inc.. View filing ↗
- Section 10a, Medpace, Inc. reciprocity. DEF 14A. Medpace, Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health, Inc.. View filing ↗
- Section 10a, Nutanix, Inc. reciprocity. DEF 14A. Nutanix, Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health, Inc.. View filing ↗
- Section 10a, Premier Inc. reciprocity. DEF 14A. Premier Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health, Inc.. View filing ↗
- Section 10a, RingCentral, Inc. reciprocity. DEF 14A. RingCentral, Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health, Inc.. View filing ↗
- Section 10a, Twilio Inc. reciprocity. DEF 14A. Twilio Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health, Inc.. View filing ↗
- Section 10a, Agilon Health, Inc. reciprocity. DEF 14A. Agilon Health, Inc. names Teladoc Health, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Alignment Healthcare, Inc. reciprocity. DEF 14A. Alignment Healthcare, Inc. names Teladoc Health, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Aveanna Healthcare Holdings Inc. reciprocity. DEF 14A. Aveanna Healthcare Holdings Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health, Inc.. View filing ↗
- Section 10a, Dropbox, Inc. reciprocity. DEF 14A. Dropbox, Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health, Inc.. View filing ↗
- Section 10a, Maximus Inc. reciprocity. DEF 14A. Maximus Inc.'s most recent proxy was read; its disclosed peer group does not include Teladoc Health, Inc.. View filing ↗
- Section 10a, Privia Health Group, Inc. reciprocity. DEF 14A. Privia Health Group, Inc. names Teladoc Health, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗